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Abstract: The Gwich’in, which belong to the Athapaskan language group of Native Americans live in the borderland between 
Alaska and Canada. We analyzed 29 medicinal plants of this tribe for their growth inhibitory activity against CCRF-CEM T-cell 
acute lymphoblastic leukemia (T-ALL) cells. The anti-leukemic activity of these plants has not been investigated as yet. Considering
the poor cure rates of some ALL forms, there might be a great potential for medicinal plants as resource for natural products to treat 
T-ALL. We found that the hexane extracts of three plants revealed considerable growth inhibition on CCRF-CEM cells. The 50% 
inhibition concentrations (IC50) were 6.63 ± 0.03 µg/ml for Cladina mitis, 8.65 ± 0.38 µg/ml for Picea mariana (needles), and 9.67 
± 1.36 µg/ml for Artemisia frigida. Further investigations are required to isolate the active constituents of these plants. 
Keywords: cytotoxicity, herbs, leukemia, medicinal plants, pharmacognosy
Introduction 
The Athapaskans are a large language family of Native 
Americans living in Alaska and Canada as well as in the 
southwest and west coast of USA. The name Athapaskaw 
means “everywhere is pasture and reed” and refers to a region 
westward of Athabasca Lake (Alberta, Canada). They mainly 
live from hunting and fishing and in more recent times from 
fur trade with Europeans. In the borderland between Alaska 
and Canada, the Kutchin Athapaskans are located which are 
subdivided in Gwich’in, Loucheux and Takudh. In the present 
investigation, we analyzed medicinal plants of the Gwich’in. 
Due to the harsh climate and rough living conditions,  
medicinal plants played an important role in the everyday life 
of the Native Americans in these regions. 
In the past decades, several papers reported on the  
ethnobotanical knowledge of these tribes.1–9 An inventory of 
medicinal plants of the Carrier, a tribe belonging to the  
Athapaskan group in North-central British Columbia has been 
reported.7 Systematic analyses on the pharmacological activity 
of medicinal herbs from these tribes are largely missing as of 
yet. Furthermore, professional timber practices and absorption 
into modern civilization foster the extinction of medicinal 
plant species and the loss of indigenous knowledge about  
medicinal plants. 
Interestingly, some characteristics of traditional medicine of 
these tribes are shared with other traditional medicine systems 
in other parts of the world, e.g. Asia, Africa, or South-America, 
speaking for an ancient knowledge about medicinal plants 
tracing back to the early days of manhood as human beings 
migrated to inhabit our planet. These common features of any 
traditional medicine include e.g. respect for nature and staying 
in a balance with nature. This is also true for the traditional 
medicine of the Gwich’in. In their view, diseases result from 
imbalances between the spiritual and physical world and the 
task of shamans is to identify such imbalances and treat them 
by medicinal plants and other means. Plants are collected with 
a sense of respect and conservation for nature. Single herbs or 
mixtures are applied as decoctions or infusions for internal use 
or as ointments, salves and washing solutions for external use. 
The Wilderness International Foundation is a non-
governmental organization (NGO) helping to preserve wilder-
ness areas and halt widespread environmental damage. To this 
end, residents and institutions of the endangered areas are  
involved in the activities of this NGO. The foundation  
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maintains a nature preservation project in the Peel River  
Watershed in North-West Canada, where the Gwich’in and 
Nacho Nyak Dun “First Nations” are resided. Gaining more 
knowledge on medicinal plants of the Gwich’in is part of the 
nature preservation project and was a starting point of the  
present investigation. 
We focused on the cytotoxic activity of medicinal plants of 
Gwich’in against leukemia cells, because there is a great need 
for improvement of therapy options worldwide. Acute  
lymphoblastic leukemia (ALL) is the most common malignancy
among children and represents 60% of childhood and 10–20% 
of adult acute leukemia.10 The overall ALL incidence rate per 




Untreated ALL is rapidly fatal, with death occurring in 
weeks to a few months commonly as a consequence of bone 
marrow failure or space-occupying lesions.10 In the past  
decades, the understanding and therapy of childhood ALL has 
improved a lot, transforming the disease from a rapidly  
progressive and usually lethal disorder to a disease with an 
80% cure rate.11 Unfortunately, the cure rates of ALL in adults 
rarely exceed 40%.11 The poor outcome for adult ALL is  
probably attributed to drug resistance, poorer tolerance of 
treatment, and less effective treatment regimens compared 
with childhood ALL.11 Furthermore, response to treatment is 
varying strongly depending on ALL subtype.12 Although  
specific treatment approaches may differ for every patient, 
treatment of ALL generally consists of three phases: remission-
induction phase, consolidation phase and continuation therapy 
to eliminate residual disease.11,13 Unfortunately, little progress 
has been made for relapsed and refractory ALL.14 Furthermore, 
treatment includes high doses of chemotherapeutics resulting 
in serious acute and late complications in many patients.15,16 
Thus, there is a significant need for more effective treatments 
of ALL. 
In this context, a promising approach is to utilize the  
potential of natural products, especially from medicinal plants. 
Due to the structural diversity of their phytochemical  
compounds, natural products provide an excellent resource for 
the identification of novel active agents that may serve as leads 
and scaffolds for new, more effective drugs in cancer therapy. 
In the past decades, numerous novel natural compounds with 
anti-cancer activity have been identified and characterized.17 
Meanwhile, many of them belong to the standard repertoire of 
cancer chemotherapy.18 In fact, the relevance of natural  
products in cancer treatment is emphasized by statistics  
indicating that natural products and their derivatives account 
for half of all anti-cancer drugs approved world-wide between 
the 1940s and 2006.19 About 75% of plant-derived drugs that 
are in clinical use attracted attention because of their use in 
traditional medicines indicating the significance of medicinal 
plants for the identification of novel anti-cancer drugs.19  
Considering that only 5,000 of 250,000 to 300,000 known 
plant species have been studied for possible medical application
so far, 19 there is still a great treasure waiting to be exploited 
for drug development. 
The objective of the present investigation was to identify 
medicinal plants that might serve as resources for chemical 
compounds to treat T-cell ALL. The growth inhibitory activity 
of medicinal plants was evaluated in vitro towards human 
CCRF-CEM leukemia cells. Our investigation focused on 29 
medicinal plants of the Gwich’in, whose anti-cancer activity 
had not been investigated yet. 
 
Results and Discussion 
Screening of Extracts from Medicinal Plants. The results 
of the screening of plant extracts at a fixed concentration (10 
µg/ml) are summarized in Figure 1. The screening of hexane 
extracts revealed three hits with an inhibition of leukemia cell 
growth of more than 60% (Fig. 1A). Cladina mitis (CM) had 
the highest anti-proliferation activity towards CCRF-CEM 
leukemia cells (nearly 90% inhibition). Needles of Picea  
mariana (PM-N) showed a comparable high cytotoxicity  
reducing cell viability to approx. 15% of untreated control. 
Cell viability of CCRF-CEM cells treated with 10 µg/ml of 
Artemisia frigida (AF) was reduced to 35% of control. Except 
for Ledum groenlandicum (LG), which showed a modest  
cytotoxic effect (cell viability of less than 60%), all other  
hexane extracts did not reveal anti-proliferative activity  
towards CCRF-CEM leukemia cells. Ethanol extracts did not 
show considerable cytotoxic effects towards CCRF-CEM  
leukemia cells (Fig. 1B). Achillea millefolium (AM), Aconitum 
delphiniifolium (AD) and Arnica alpina (AA) rather seemed to 
induce proliferation of CCRF-CEM leukemia cells. Solidago 
spathulata (SS) showed minimal inhibitory activity. Methanol 
extracts did also not considerably inhibit leukemia cell growth 
(Fig. 1C). The screening of ethyl acetate extracts showed 
comparable results (Fig. 1D). Only Artemisia frigida (AF) 
showed minimal anti-proliferative activity towards CCRF-
CEM leukemia cells with a cell viability of about 80% of  
control. 
Dose-Response Curves of Active Plant Extracts. To  
analyze the active extracts in more detail, the dose-response 
curves of the hexane extracts Cladina mitis, Picea mariana 
Figure 1.  Activity of plant extracts towards CCRF-CEM 
leukemia cells. Cell viability is represented by mean ±SEM of 
two independent cell viability tests (each with 6 parallel 
measurements) and is expressed as percentage survival of 
control (cell growth in medium with solvent). (A) n-hexane 
extracts; (B) ethanol extracts; (C) methanol extracts; (D) ethyle 
acetate extracts. The abbreviations for the plants are given in 
Table 1.
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(needles) and Artemisia frigida were performed in a dose 
range from 0.01 to 30 µg/ml. As shown in Figure 2 and Table 
2, the strongest cytotoxic effect was observed in the Cladina 
mitis extract, which had the lowest IC50 value (6.63 ± 0.03 
µg/ml). Picea mariana (needles) also showed considerable cell 
growth inhibition (IC50 value: 8.65 ± 0.38 µg/ml). Artemisia 
frigida showed modest activity towards CCRF-CEM leukemia 
cells (IC50 value: 9.67 ± 1.36 µg/ml). 
The screening of hexane extracts of medicinal plants from 
the Gwich’in, a Native American tribe from Northwestern 
Canada, revealed three plants with anti-proliferative effects 
against CCRF-CEM leukemia cells. Cladina mitis (Green 
Reindeer lichen) has been traditionally applied as tea to treat 
colds, arthritis, fever and pain in stomach and chest.  
Furthermore, it has been used as a poultice to relieve pain in 
arthritic joints and as treatment of tuberculosis. The hexane 
extract of this plant had the strongest cytotoxic effect in the 
present investigation. The second active compound was Picea 
mariana (needles), which has traditionally been used as tea 
against cough and costiveness. The third moderately active 
plant extract was Artemisia frigida (Pasture sage/Prairie sage) 
that has traditionally been used as tea against severe cold and 
sore throat and as repellent against mosquitoes, bugs, flea and 
lice. Extracts of these plants prepared with other solvents  
(ethanol, methanol, ethylacetate) were inactive. This speaks 
for specific plant constituents solved in n-hexane that reveal 
cytotoxicity but not in other solvents. 
In general, it can be expected that medicinal plants from  
traditional medicines contain still unknown natural products 
with activity towards cancer cells. Examples from the past are 
the Vinca alkaloids from the Madagaskan Catharanthus roseus 
and paclitaxel from the Pacific yew (Taxus brevifolia) and 
related species, e.g. Taxus chinensis. A plant used by  
North-American First Nations for the treatment of warts is 
Podophyllum peltatum. Its active constituent, podophylloxotin, 
served as lead compound for the development of etoposide and 
teniposide, two clinically well-established anti-cancer drugs. 
Whether the three plants identified in the present study contain 
compounds with strong cytotoxicity is still unknown. It is also 
possible that a combination of different compounds each with 
weak or intermediate bioactivity act together resulting in a 
synergistic manner. Previous investigations reported the  
isolation of secondary metabolites from Artemisia frigida and 
Picea mariana.29–31 Whether these compounds reveal anti-
leukemic activity and whether or not synergistic interactions 
of different constituents are responsible for cytotoxicity needs 
to be investigated in more detail in the future. Furthermore, 
whether these plants reveal cytotoxicity to cell lines of solid 
cancers merits further investigations. 
A promising outcome of this study is that it is possible to 
identify cytotoxic extracts from this panel of plants. This  
raises the hope that novel phytochemicals may be isolated 
from medicinal plants of the Gwich’in Native Americans. 
While medicinal plants have a long tradition among the tribes 
of Native Americans, a systematic screening and exploitation 
for therapeutic purposes with modern pharmacological and 
biological methods has still to be realized. 
 
Experimental Section 
Cell Line. The CCRF-CEM cell line is a T lymphoblastic 
cell line obtained from the peripheral blood of a 4-years old 
Caucasian female with acute lymphoblastic leukemia20 and has 
widely been used as model cell line for T-ALL.21–23 Human 
CCRF-CEM leukemia cells were maintained in RPMI 1640 
medium (Gibco BRL, Eggenstein) supplemented with 10% 
fetal bovine serum (Gibco BRL, Trace) and 1% penicil-
lin/streptomycin (Gibco, Invitrogen) in a 5% CO2 atmosphere 
at 37 °C. Cells were passaged twice a week and medium was 
changed every two days. 
 
Plant Extracts. Plants were collected within a nature  
conservation expedition of the Wilderness International  
foundation in the Three Rivers Region (Peel River Watershed) 
in the border area between the Yukon Territory and the 
Northwest Territories in the northwest of Canada. A survey of 
the plants and their traditional applications within the 
Gwich’in tribes can be seen in Table 1.24–26 Extraction was 
performed using ethanol, methanol, n-hexane or ethyl acetate 
as solvents. Botanical identification was done by two of the 
authors (K.A. and G.A.) and verified by Prof. Martin Grube 
(Institute for Plant Science, University of Graz, Austria). 
Voucher specimens are deposited at the Department for  




Figure 2.  Dose response curves of hexane extracts of three 
medicinal plants of the Gwich’in as measured by the XTT 
assay. (A) Artemisia frigida, (B) Picea mariana (needles), and 
(C) Cladonia mitis 
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Table 1. Survey of medicinal plants from the Gwich’in Native Americans, which were tested for their growth inhibitory activity 
towards CCRF-CEM leukemia cells. Information about traditional application was obtained from the Gwich’in people during a 
nature conservation expedition of the Wilderness International foundation and complemented with information from references 
(Mackinnon et al., 1999; Page, 2004; http://chem.sis.nlm.nih.gov/chemidplus/.). 
Common Name Scientific Name Abbr. Extract Traditional Application 
Alpine Arnica Arnica alpina AA EtOH Preparation of tea; stomach trouble; turgor and effusion 
Arctic Lupine Lupinus arcticus LA EtOH Seeds toxic, if eaten in large quantities; contains alkaloids 
Alpine Sweetvetch Hedysarum alpinum HA Hex, EtOAc, 
MeOH 
Boiled or roasted roots used as raw vegetables; against diarrhea; 
as a replacement for licorice 
Bearberry/ Kinnikinnick Arctostaphylos uva-ursi AU EtOH Berries and petals (in spring) alimental; dried and roasted leaves 
in tobacco mixtures; leaves used for diuretic tea; halms used for 
wound healing 
Black Crowberry Empetrum nigrum EN Hex, EtOAc, 
MeOH 
Jam; nutrition; tea made from roots and berries against stomach 
pain and cold; brewing 
Black spruce (resin) Picea mariana PM-R Hex, EtOAc, 
MeOH 
Chewing gum; wound healing; tea against sore throat; salve 
greased on the chest against bronchial diseases 
Black spruce (needles) Picea mariana PM-N Hex, EtOAc, 
MeOH 
Tea against cough and costiveness; stomach disease because of 
tobacco abuse 
Black spruce (cones) Picea mariana PM-C Hex, EtOAc, 
MeOH 
Tea against cold and cough 
Cloudberry Rubus chamaemorus RC EtOH Berries are vitamin C-containing; nutrition; sap against hives 
Common Blueberry Vaccinium uliginosum VU EtOH Halms and leaves used in tea against cold; stress repressive
Common Snowberry Symphoricarpos albus SA Hex, EtOAc, 
MeOH 
Berries are toxic; symptoms include vomiting and diarrhea 
Cranberry Vaccinium vitis-idaea VV EtOH Nutrition; sap of berries used against trouble with the kidney or 
digestion and against cold; leaves used in tea against cough; 
anti-inflammatory 
Dwarf Scouring Rush Equisetum scirpoides ES Hex, EtOAc, 
MeOH 
Raw as nutrition; leaves and halms cooked and used against 
cold, rheumatism, stomach pain, inflammations and kidney 
disease 
Elephant’s head Pedicularis groenlandica PGr Hex, EtOAc, 
MeOH 
Young blade and roots as raw vegetables or soft boiled; used 
against fever, contusion and insomnia 
Fireweed Epilobium angustifolium EA EtOH Sap against skin rash; leaves used as poultice against burning, 
bee-stings, pain and turgor; nutrition; anti-inflammatory 
Frog Orchid Coeloglossum viride CV EtOH, Hex, 
EtOAc, MeOH
No known applications 
Gorman’s Beardtongue Penstemon gormanii PGo EtOH Used against toothache 
Green Reindeer lichen Cladina mitis CR EtOH, Hex, 
EtOAc, MeOH
Used in medicinal tea to treat colds, arthritis, pain in stomach 
and chest and fever; poultice to relieve pain in arthritic joints; 
treatment of tuberculosis 
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Labrador Tea Ledum groenlandicum LG EtOH, Hex, 
EtOAc, MeOH
Tea made of leaves and blossoms against fatigue and stomach 
ache; evacuent; eases breathing for people with tuberculosis and 
other respiratory ailments 
Meadow Alumroot Heuchera chlorantha HC EtOH, Hex, 
EtOAc, MeOH
Poultice made of roots used for wound healing and to stop 
bleeding 
Mountain Monkshood Aconitum delphiniifolium AD EtOH Highly toxic; contains alkaloide aconitine; in little doses used 
against rheumatism and cold 
Northern Grass of Parnassus Parnassia palustris PP EtOH Sedative; abatement of spasm 
Northern Sweetvetch Hedysarum boreale HB EtOH, Hex, 
EtOAc, MeOH
Roots are chewed, sweetish taste 
Shrubby Cinquefoil Potentilla fruticosa PF EtOH No medical application; used for cushion 
Spikelike Goldenrod Solidago spathulata SS EtOH Contains gum in the sap 
Pink Wintergreen Pyrola asarifolia PA EtOH, Hex, 
EtOAc, MeOH
Used against rheumatism; wound healing; analgesic; used in tea 
against cough and renal and liver disorders 
Prairie Sage/ Pasture Sage Artemisia frigida AF Hex, EtOAc, 
MeOH 
Inhalation against cold; Tea against severe cold and sore throat; 
used against mosquitoes, bugs, flea and lice; anti-inflammatory 
Willow herb Epilobium montanum EM EtOH Young plants without blossoms for nutrition 
Yarrow Achillea millefolium AM EtOH Used in tea against cough and nosebleed; alleviates skin 
irritation and sunburn; against insect bites; stops bleeding of 




Table 2. 50% Inhibitory concentration (IC50) values of CCRF-CEM leukemia cells for Artemisia frigida, Picea mariana 
(needles) and Cladina mitis extracts. IC50 values were calculated from dose-response curves by logarithmic regression. Tests 
were performed at a dose range from 0.01 to 30 µg/ml. 
Scientific name Common Name IC50 value [µg/ml] 
Artemisia frigida Pasture Sage/Prairie sage 9.67 ± 1.36 
Picea mariana Black spruce (needles) 8.65 ± 0.38 
Cladina mitis Green reindeer lichen 6.63 ± 0.03 
 
XTT Proliferation Assay. The toxicity of compounds was 
determined by means of the Cell Proliferation Kit II (Roche 
Diagnostics, Mannheim, Germany). This test is based on the 
cleavage of the yellow 2,3-bis[2-methoxy-4-nitro-5-sulfo-
phenyl]-2H-tetrazolium-5-carboxanilide inner salt (XTT) by 
ubiquitous dehydrogenases leading to the formation of an  
orange formazan dye.27 The amount of dye is commensurate to 
the number of metabolically active cells. The assay was  
performed as previously described.28 
 
Acknowledgments 
We kindly acknowledge the support of the Gwich’in people 
(especially the team of Gladys Alexie from Fort McPherson, 
Northwest Territories, Canada) and of our internship students 
(Julia Schuler, Jakob Winter, Hannes Holtermann) from  
Dresden, Germany, who visited our laboratory and helped us 
to perform the experiments. 
 
Open Access This article is distributed under the terms of the  
Creative Commons Attribution License which permits any use,  
distribution, and reproduction in any medium, provided the original 
author(s) and source are credited. 
 
References 
[1] Smith, H. I. National Museum of Canada Bulletin. 1928, 56, 445–
522. 
[2] Chandler, R. F. ;Freeman, L.; Hooper, S. N. J. Ethnopharmacol. 
1979, 1, 49–68. 
[3] Gottesfeld, L. J. J. Ethnobiol. 1994, 14, 185–210. 
[4] Gottesfeld, L. J.; Anderson, B. J. Ethnobiol. 1988, 8, 13–33. 
[5] Turner, N. J. Food plants of British Columbia Indians. Part 2. 
Interior People. handbook 36, BC Provincial Museum, Victoria, 
1978, pp 14–19. 
[6] Turner, N. J.; Hebda, R. J. J. Ethnopharmacol. 1990, 29, 59–72. 
[7] Ritch-Krc, E. M.; Thomas, S.; Turner, N. J.; Towers, G. H. J. 
Ethnopharmacol. 1996, 52, 85–94. 
[8] Moerman, D. E. Native American Ethnobotany. Timber Press, 
40      K. DEEG et al.                                                                                                                              Nat. Prod. Bioprospect. 2012, 2, 35–40 
 
         
Portland, London, 9th printing. 2010. 
[9] Moerman, D. E.; Estabrook, G. F. J. Ethnopharmacol. 2003, 87, 
51–59. 
[10] Runge, M. S. (ed.) Principles of molecular medicine. Humana 
Press: Totowa, NJ. 2nd ed. 2006. 
[11] Pui, C. H.; Evans W. E. N. Engl. J. Med. 2006, 354, 166–178. 
[12] Pui, C. H.; Robison, L. L.; Look, A. T. Lancet 2008, 371, 1030–
1043. 
[13] Silverman, L. B.; Sallan, S. E. Curr. Opin. Hematol. 2003, 10, 
290–296. 
[14] Jeha, S. Semin. Hematol. 2009, 46, 76–88. 
[15] Pui, C. H.; Cheng, C.; Leung, W.; Rai, S. N.; Rivera, G. K.; 
Sandlund, J. T.; Ribeiro, R. C.; Relling, M. V.; Kun, L. E.; Ev-
ans, W. E.; Hudson, M. M. N. Engl. J. Med. 2003, 349, 640–649. 
[16] Oeffinger, K. C.; Hudson, M. M. CA Cancer J. Clin. 2004, 54, 
208–236. 
[17] Efferth, T.; Sauerbrey, A.; Olbrich, A.; Gebhart, E.; Rauch, P.; 
Weber, H. O.; Hengstler, J. G.; Halatsch, M. E.; Volm, M.; Tew, 
K. D.; Ross, D. D.; Funk, J. O. Mol. Pharmacol. 2003, 64, 382–
394. 
[18] Efferth, T.; Li, P. C.; Konkimalla, V. S.; Kaina, B. Trends Mol. 
Med. 2007, 13, 353–361. 
[19] Newman, D. J.; Cragg, G. M. J. Nat. Prod. 2007, 70, 461–477. 
[20] Hay, R. J.; Williams, C. D.; Macy, M. L.; Lavappa, K. S. Am. 
Rev. Respir. Dis. 1982, 125, 222–232. 
[21] Kofler, R. Histochem. Cell Biol. 2000, 114, 1–7. 
[22] Efferth, T.; Davey, M.; Olbrich, A.; Rücker, G.; Gebhart, E.; 
Davey, R. Blood Cells Mol. Dis. 2002, 28, 160–168. 
[23] Lambrou, G. I.; Vlahopoulos, S.; Papathanasiou, C.; Papaniko-
laou, M.; Karpusas, M.; Zoumakis, E.; Tzortzatou-Stathopoulou, 
F. Leuk Res. 2009, 33, 1684–1695. 
[24] Mackinnon, A.; Pojar, J.; Coupe, R. Plants of the Northern Brit-
ish Columbia. Expanded 2nd ed. Lone Pine Publishing. 1999. 
[25] Andre, A.; Fehr, A. Gwich'in Ethnobotany: Plants Used by the 
Gwich'in for Food, Medicine, Shelter and Tools. Tsiigehtchic, 
North West Territories, Canada: Gwich'in Social and Cultural 
Institute. 2001. 
[26] Page, B. Barrenland Beauties, Showy Plants of the Canadian 
Arctic. Yellowknife, North West Territories, Canada: Outcrop, 
The Northern Publishers. 2004. 
[27] Scudiero, D. A.; Shoemaker, R. H.; Paull, K. D.; Monks, A.; 
Tierney, S.; Nofziger, T. H.; Currens, M. J.; Seniff, D.; Boyd, M. 
R. Cancer Res. 1988, 48, 4827–4833. 
[28] Konkimalla, V. B.; Efferth, T. Biochem. Pharmacol. 2010, 80, 
39–49. 
[29] Lopes-Lutz, D.; Alviano, D. S.; Alviano, C. S.; Kolodziejczyk, P. 
P. Phytochemistry 2008, 69, 1732–1738. 
[30] Wang, Q. H.; Ao, W. L. J.; Wang, X. L.; Bao, X. H.; Wang, J. H. 
J. Asian Nat. Prod. Res. 2010, 12, 950–954. 
[31] http://www.ars-grin.gov/cgi-bin/duke/farmacy2.pl. (accession 
date: February 12th, 2012) 
 
